Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 13/20 | 0.46 |
| ▸ | LPL | P06858 | 12/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.34 |
| ▸ | CSF1R | P07333 | 1/20 | 0.34 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.33 |
| ▸ | KDR | P35968 | 1/20 | 0.33 |
| ▸ | P4HB | P07237 | 1/20 | 0.32 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.31 |
| ▸ | AHR | P35869 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22045661 | 0.97 | LIPG (0.49) | LIPGLPLALOX5CSF1RPDGFRB | |
| SCHEMBL22045389 | 0.91 | LIPG (0.39) | LIPGLPLALOX5CSF1R | |
| SCHEMBL22045766 | 0.90 | LPL (0.37) | LIPGLPL | |
| SCHEMBL22045767 | 0.89 | LIPG (0.39) | LIPGLPLALOX5CSF1R | |
| SCHEMBL17700992 | 0.88 | LIPG (0.47) | LIPGLPLALOX5P4HBDGAT1 | |
| SCHEMBL22045387 | 0.88 | LIPG (0.37) | LIPGLPLALOX5CSF1R | |
| SCHEMBL22045684 | 0.86 | LIPG (0.40) | LIPGLPLALOX5CSF1R | |
| SCHEMBL12925749 | 0.85 | LIPG (0.46) | LIPGLPLALOX5CSF1R | |
| SCHEMBL24434088 | 0.85 | LIPG (0.46) | LIPGLPLALOX5CSF1R | |
| SCHEMBL22045693 | 0.85 | CSF1R (0.35) | LIPGLPLCSF1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11512076-B2 | Compound for organic electronic element, organic electronic element comprising the same, and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2022-11-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11512076-B2 | Compound for organic electronic element, organic electronic element comprising the same, and electronic device thereof | PIEZO1, OCIAD1, LEF1 | LIPG 1174/4885LPL 3024/4885ALOX5 1372/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.